Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia.
Carreras E, Jiménez M, Gómez-García V, de la Cámara R, Martín C, Martínez F, Iriondo A, Sanz G, Cañizo C, Cabrera R, Sierra J, Vallejo C, López J, Martínez C, Rovira M, Fernández-Rañada JM, Torres A. Carreras E, et al. Among authors: canizo c. Bone Marrow Transplant. 2006 Jan;37(1):33-40. doi: 10.1038/sj.bmt.1705195. Bone Marrow Transplant. 2006. PMID: 16247421
Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: outcome and prognostic factors: the Chronic Myeloid Leukemia Subcommittee of the GETH (Grupo Español de Trasplante Hemopoyético).
Martínez C, Gomez V, Tomás JF, Parody R, Sureda A, Sanz G, Cañizo C, Díez JL, Boqué C; CML Subcommittee of the Spanish Group of Hematopoietic Transplantation (Grupo Español de Trasplante Hemopoyética, GETH). Martínez C, et al. Among authors: canizo c. Bone Marrow Transplant. 2005 Aug;36(4):301-6. doi: 10.1038/sj.bmt.1705063. Bone Marrow Transplant. 2005. PMID: 15968278
Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.
Martino R, Pérez-Simón JA, Moreno E, Queraltó JM, Caballero D, Mateos M, Sureda A, Cañizo C, Brunet S, Briones J, Vazquez L, Clopés A, San Miguel JF, Sierra J. Martino R, et al. Among authors: canizo c. Biol Blood Marrow Transplant. 2005 Jun;11(6):437-47. doi: 10.1016/j.bbmt.2005.03.003. Biol Blood Marrow Transplant. 2005. PMID: 15931632 Free article.
Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBT.
de la Rubia J, Martínez C, Solano C, Brunet S, Cascón P, Arrieta R, Alegre A, Bargay J, de Arriba F, Cañizo C, López J, Serrano D, Verdeguer A, Torrabadella M, Díaz MA, Insunza A, de la Serna J, Espigado I, Petit J, Martínez M, Benlloch L, Sanz M. de la Rubia J, et al. Among authors: canizo c. Bone Marrow Transplant. 1999 Oct;24(7):723-8. doi: 10.1038/sj.bmt.1701977. Bone Marrow Transplant. 1999. PMID: 10516674
Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation.
Pérez-Simón JA, García-Escobar I, Martinez J, Vazquez L, Caballero D, Cañizo C, Mateos MV, San Miguel JF. Pérez-Simón JA, et al. Among authors: canizo c. Bone Marrow Transplant. 2004 Jan;33(2):183-7. doi: 10.1038/sj.bmt.1704335. Bone Marrow Transplant. 2004. PMID: 14647255 Clinical Trial.
Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome.
Valcárcel D, Ademà V, Solé F, Ortega M, Nomdedeu B, Sanz G, Luño E, Cañizo C, de la Serna J, Ardanaz M, Marco V, Collado R, Grau J, Montoro J, Mallo M, Vallespí T. Valcárcel D, et al. Among authors: canizo c. J Clin Oncol. 2013 Mar 1;31(7):916-22. doi: 10.1200/JCO.2012.41.6073. Epub 2013 Jan 14. J Clin Oncol. 2013. PMID: 23319689
Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.
Pérez-Simon JA, López-Villar O, Andreu EJ, Rifón J, Muntion S, Diez Campelo M, Sánchez-Guijo FM, Martinez C, Valcarcel D, Cañizo CD. Pérez-Simon JA, et al. Among authors: canizo cd. Haematologica. 2011 Jul;96(7):1072-6. doi: 10.3324/haematol.2010.038356. Epub 2011 Mar 10. Haematologica. 2011. PMID: 21393326 Free PMC article. Clinical Trial.
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes.
Saumell S, Florensa L, Luño E, Sanzo C, Cañizo C, Hernández JM, Cervera J, Gallart MA, Carbonell F, Collado R, Arenillas L, Pedro C, Bargay J, Nomdedeu B, Xicoy B, Vallespí T, Raya JM, Belloch L, Sanz GF, Solé F. Saumell S, et al. Among authors: canizo c. Br J Haematol. 2012 Nov;159(3):311-21. doi: 10.1111/bjh.12035. Epub 2012 Sep 7. Br J Haematol. 2012. PMID: 22958186 Free article.
108 results